[ad_1] The FDA has approved the first bioidentical hormone therapy combination of estradiol and progesterone for moderate to severe vasomotor symptoms associated with menopause, Therapeutics® reported in a press release. The approval …
Read More »[ad_1] The FDA has approved the first bioidentical hormone therapy combination of estradiol and progesterone for moderate to severe vasomotor symptoms associated with menopause, Therapeutics® reported in a press release. The approval …
Read More »